No abstract

No abstract

No abstract

No abstract

The frequency and mass concentrations of 13 herbicide micropollutants (triazines, phenylureas, chloroacetanilides and trifluralin) were investigated during 2014 in surface, ground and drinking waters in the area of the city of Zagreb and its suburbs. Herbicide compounds were accumulated from water by solid-phase extraction using either octadecylsilica or styrene-divinylbenzene sorbent cartridges and analysed either by high-performance liquid chromatography with UV-diode array detector or gas chromatography with mass spectrometric detection. Atrazine was the most frequently detected herbicide in drinking (84 % of samples) and ground (61 % of samples) waters in mass concentrations of 5 to 68 ng L. It was followed by metolachlor and terbuthylazine, the former being detected in 54 % of drinking (up to 15 ng L) and 23 % of ground (up to 100 ng L) waters, and the latter in 45 % of drinking (up to 20 ng L) and 26 % of ground (up to 25 ng L) water samples. Acetochlor was the fourth most abundant herbicide in drinking waters, detected in 32 % of samples. Its mass concentrations of 107 to 117 ng L in three tap water samples were the highest of all herbicides measured in the drinking waters. The most frequently (62 % of samples) and highly (up to 887 ng L) detected herbicide in surface waters was metolachlor, followed by terbuthylazine detected in 49 % of samples in mass concentrations of up to 690 ng L, and atrazine detected in 30 % of samples in mass concentrations of up to 18 ng L. The seasonal variations in herbicide concentrations in surface waters were observed for terbuthylazine, metolachlor, acetochlor, chlortoluron and isoproturon with the highest concentrations measured from April to August.

No abstract

No abstract

Nerve agents, the deadliest chemical warfare agents, are potent inhibitors of acetylcholinesterase (AChE) and cause rapid cholinergic crisis with serious symptoms of poisoning. Oxime reactivators of AChE are used in medical practice in the treatment of nerve agent poisoning, but the search for novel improved reactivators with central activity is an ongoing pursuit. For numerous oximes synthesized, in vitro reactivation is a standard approach in biological evaluation with little attention given to the pharmacokinetic properties of the compounds. This study reports a comprehensive physicochemical, pharmacokinetic, and safety profiling of five lipophilic 3-hydroxy-2-pyridine aldoximes, which were recently shown to be potent AChE reactivators with a potential to be centrally active. The oxime JR595 was singled out as highly metabolically stable in human liver microsomes, noncytotoxic oxime for SH-SY5Y neuroblastoma and 1321N1 astrocytoma cell lines, and its pharmacokinetic profile was determined after intramuscular administration in mice. JR595 was rapidly absorbed into blood after 15 min with simultaneous distribution to the brain at up to about 40% of its blood concentration; however, it was eliminated from both the brain and blood within an hour. In addition, the MDCKII-MDR1 cell line assay showed that oxime JR595 was not a P-glycoprotein efflux pump substrate. Finally, the preliminary antidotal study against multiple LD 50 doses of VX and sarin in mice showed the potential of JR595 to provide desirable therapeutic outcomes with future improvements in its circulation time.